(19)
(11) EP 1 409 015 A1

(12)

(43) Date of publication:
21.04.2004 Bulletin 2004/17

(21) Application number: 02704253.0

(22) Date of filing: 25.01.2002
(51) International Patent Classification (IPC)7A61K 39/395, A61K 39/00, A61K 38/00
(86) International application number:
PCT/US2002/002314
(87) International publication number:
WO 2002/060480 (08.08.2002 Gazette 2002/32)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 01.02.2001 US 265964 P

(71) Applicants:
  • BIOGEN, INC.
    CambridgeMassachusetts 02142 (US)
  • UNIVERSITY HOSPITALS OF CLEVELAND
    Cleveland,Ohio 44106 (US)

(72) Inventors:
  • VAISHNAW, Akshay, K.
    Arlington, MA 02474 (US)
  • COOPER, Kevin, D.
    Moreland Hills, OH 44022 (US)
  • SCHRAGER, Daniel
    Princeton, NJ 08540 (US)
  • MCCORMICK, Thomas, S.
    Orange Village, OH 44022 (US)

(74) Representative: VOSSIUS & PARTNER 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) METHODS FOR TREATING OR PREVENTING SKIN DISORDERS USING CD2-BINDING AGENTS